Skip to main content
Clinical Trials/DRKS00025974
DRKS00025974
Recruiting
未知

The effect of interventions focussing on or leading away from actual symptoms on well-being in different states of altered neuroplasticity - EFAAP

niversitätsklinikum Freiburg0 sites88 target enrollmentSeptember 21, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
F32.2
Sponsor
niversitätsklinikum Freiburg
Enrollment
88
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 21, 2021
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 18 to 50 years
  • Sex distribution:
  • Patients will be enrolled in the trial independent of their sex or sexual orientation.
  • Mayor depressive disorder according to ICD\-10: F32\.2, F33\.2 criteria.
  • 2 weeks constant pharmacotherapy

Exclusion Criteria

  • Bipolar disorder (ICD\-10: F31\.X)
  • Co\-morbid post\-traumatic\-stress\-disease (PTSD; ICD\-10: F43\.1\)
  • Co\-morbid personality disorder (ICD\-10: F60\.X)
  • Co\-morbid psychotic disease (ICD\-10: F2X)
  • Co\-morbid addictive disorder (ICD\-10: F1X)
  • Current co\-morbid neurological diseases (ICD\-10: GX)
  • Co\-medication with Benzodiazepines, Pregabalin, opioids, inhibitors of MAO and z\-substances
  • Co\-treatment with other stimulative treatment interventions like electroconvulsive therapy, transcranial direct current stimulation or deep brain stimulation.

Outcomes

Primary Outcomes

Not specified

Similar Trials